Concepedia

Smaranda Bodea

SB

8

Publications

718

Citations

8

H-Index

2015

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

Howard Hughes Medical Institute

Center for Environmental Health

Massachusetts Institute of Technology

Smaranda Bodea is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, natural sciences, and molecular biology.

Top concepts

Publications per year

2015–2022

8

Publications

8

Characterization and Detection of a Widely Distributed Gene Cluster That Predicts Anaerobic Choline Utilization by Human Gut Bacteria

Ana Martínez-del Campo, Smaranda Bodea, Hilary A. Hamer et al. · mBio · 2015 · 221 citations · Full text

A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier

Elizabeth M. Hart, Angela M. Mitchell, Anna Konovalova et al. · Proceedings of the National Academy of Sciences · 2019 · 188 citations · Full text

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene

Mark J. Demma, Claudio Mapelli, Angie Sun et al. · Molecular and Cellular Biology · 2019 · 88 citations · Full text

Molecular Basis of C–N Bond Cleavage by the Glycyl Radical Enzyme Choline Trimethylamine-Lyase

Smaranda Bodea, Michael A. Funk, Emily P. Balskus et al. · Cell chemical biology · 2016 · 68 citations · Full text

, , +8

Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria

Marina Orman, Smaranda Bodea, Michael A. Funk et al. · Journal of the American Chemical Society · 2018 · 63 citations

, , +17

Rows per page

1–5 of 8